Sbc Medical Group Holdings Incorporated ( (SBC) ) has released its Q3 earnings. Here is a breakdown of the information Sbc Medical Group Holdings Incorporated presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SBC Medical Group Holdings Incorporated is a global provider of consulting and management services to medical corporations and their clinics, operating in diverse fields such as aesthetic medicine, dermatology, and fertility treatment, with a strong presence in the United States and Asia.
In the third quarter of 2025, SBC Medical Group reported a significant increase in profitability despite a decline in revenue. The company’s total revenues decreased by 18% year-over-year to $43 million, while net income surged by 353% to $13 million, reflecting improved operational efficiency and cost management.
Key financial highlights include a 15% increase in income from operations to $16 million and a 12% rise in EBITDA to $17 million. The company also reported a robust EBITDA margin of 38%, up from 28% in the previous year. The number of franchise locations grew by 34 to 258, and the customer base expanded by 14% to 6.5 million.
Looking forward, SBC Medical Group aims to sustain growth by focusing on high-quality solutions and expanding its multi-brand initiatives in the dermatology segment, while strengthening its business foundation in overseas markets.